JPH03197482A - Production of apovincaminic acid ester - Google Patents
Production of apovincaminic acid esterInfo
- Publication number
- JPH03197482A JPH03197482A JP33893689A JP33893689A JPH03197482A JP H03197482 A JPH03197482 A JP H03197482A JP 33893689 A JP33893689 A JP 33893689A JP 33893689 A JP33893689 A JP 33893689A JP H03197482 A JPH03197482 A JP H03197482A
- Authority
- JP
- Japan
- Prior art keywords
- chloride
- alcohol
- formula
- vincamine
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- -1 apovincaminic acid ester Chemical class 0.000 title description 6
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 claims abstract description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960002726 vincamine Drugs 0.000 claims abstract description 17
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims abstract description 10
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 claims abstract description 10
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims abstract description 8
- 239000002841 Lewis acid Substances 0.000 claims abstract description 7
- 150000007517 lewis acids Chemical class 0.000 claims abstract description 7
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims abstract description 6
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims abstract description 6
- 229940102001 zinc bromide Drugs 0.000 claims abstract description 5
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims abstract description 4
- 235000005074 zinc chloride Nutrition 0.000 claims abstract description 4
- 239000011592 zinc chloride Substances 0.000 claims abstract description 4
- 229910015900 BF3 Inorganic materials 0.000 claims abstract description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims abstract description 3
- 239000002253 acid Substances 0.000 claims description 36
- 150000002148 esters Chemical class 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 17
- 238000010992 reflux Methods 0.000 abstract description 8
- 230000002490 cerebral effect Effects 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 abstract description 2
- 230000004087 circulation Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 230000004520 agglutination Effects 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000009835 boiling Methods 0.000 description 5
- 125000004494 ethyl ester group Chemical group 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- OZDNDGXASTWERN-CTNGQTDRSA-N Apovincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-CTNGQTDRSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WKACQPMBGWZDMR-UHFFFAOYSA-N Vincamin Natural products CC=C1/CN2CCC34CC2C1C(=C3Nc5ccccc45)C=O WKACQPMBGWZDMR-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229950006936 apovincamine Drugs 0.000 description 1
- OZDNDGXASTWERN-UHFFFAOYSA-N apovincamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-UHFFFAOYSA-N 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- WLXALCKAKGDNAT-UHFFFAOYSA-N diazoethane Chemical compound CC=[N+]=[N-] WLXALCKAKGDNAT-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、アポビンカミン酸エステルの新規な製造法に
関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a novel method for producing apovincamic acid ester.
アポビンカミン酸エステルは、脳血流増加作用、微小循
環改善作用、血小板凝集抑制作用、脳代謝改善作用およ
び脳虚血保護作用などを有する薬物であり、脳循環代謝
改善剤として利用される。Apovincamic acid ester is a drug that has an effect of increasing cerebral blood flow, improving microcirculation, inhibiting platelet aggregation, improving cerebral metabolism, and protecting against cerebral ischemia, and is used as an agent for improving cerebral circulation and metabolism.
従来の技術
従来より、天然アルカロイドの一種であるビンカミンを
出発原料としたアポビンカミン酸エステルの製法は知ら
れている。その方法としては、ビンカミンあるいはビン
カミンから得られるビンカミン酸を脱水する工程とエス
テル化する工程とを組み合わせることによって行われて
いる。BACKGROUND OF THE INVENTION Conventionally, a method for producing apovincamic acid ester using vincamine, a type of natural alkaloid, as a starting material has been known. The method is carried out by combining a step of dehydrating vincamin or vincamic acid obtained from vincamine and a step of esterifying it.
脱水工程としては、
(1)220℃で熱処理する方法[:Tetrahed
ronLetters、 702(1961):l、(
2)無水酢酸中で煮沸する方法(ハンガリー特許明細書
第151295号)、
(3) ジクロロメタン中で硫酸と反応させる方法(
ハンガリー特許明細書 第160367号)、(4)オ
キシ塩化リン中で煮沸するか、または無水リン酸もしく
はハロゲン化リンと反応させる方法(ハンガリー特許明
細書 第151295号)、(5)塩酸の存在下、アル
コール中で煮沸する方法[Chem、Zvesti、、
17 、4H1963) :]、(6)強酸の存在下
、水と共沸混合物を形成する溶媒中で脱水を行わせ、水
を共沸蒸留によって連続的に除去する方法(特開昭56
−71091号公報)などが知られている。The dehydration process is as follows: (1) Heat treatment at 220°C [:Tetrahed
ron Letters, 702 (1961): l, (
2) Boiling in acetic anhydride (Hungarian Patent Specification No. 151295), (3) Reacting with sulfuric acid in dichloromethane (
Hungarian Patent Specification No. 160367), (4) boiling in phosphorus oxychloride or reaction with phosphoric anhydride or phosphorus halide (Hungarian Patent Specification No. 151295), (5) in the presence of hydrochloric acid. , method of boiling in alcohol [Chem, Zvesti,,
17, 4H1963) : ], (6) A method in which dehydration is carried out in a solvent that forms an azeotrope with water in the presence of a strong acid, and water is continuously removed by azeotropic distillation (JP-A-56
-71091) and the like are known.
エステル化工程としては、
(1) アポビンカミン酸を触媒存在下に目的とする
エステルに対応するアルコールでエステル化スる方法、
(2) アポビンカミンを対応するアルコラードと反
応させる方法、
(3)アポビンカミン酸の塩を対応するアルコールのハ
ロゲン化物またはサルフェートと反応させる方法(以上
特公昭51−32640号公報)、(4) ビンカミ
ン酸を酸クロライドとし、対応するアルコールと反応さ
せる方法(スペイン特許484651号)、
(5)アポビンカミン酸の塩を対応するアルコールのハ
ロゲン化物またはサルフェートと相間移動触媒の存在下
に反応させる方法(特開昭56138187号公報)、
(6)アポビンカミン酸の塩にジアゾエタンを反応させ
る方法 (スペイン特許525772号)、(7)
アポビンカミン酸をジメチルホルムアミド中、対応する
アルコールのハロゲン化物と金属水素化物の存在下に反
応させる方法(ドイツ特許2421999号)、
(8) アポビンカミン酸塩を対応するアルコールと
ハロゲン化スルフォニルもしくはハロゲン化炭酸エステ
ルの存在下に反応させる方法(特開昭63−93782
号公報)などが知られている。The esterification process includes (1) a method of esterifying apovincamic acid with an alcohol corresponding to the desired ester in the presence of a catalyst, (2) a method of reacting apovincamine with a corresponding alcoholade, (3) a method of esterifying apovincamic acid with an alcohol corresponding to the desired ester, and (3) a method of reacting apovincamic acid with an alcohol corresponding to the desired ester. A method of reacting a salt with a halide or sulfate of a corresponding alcohol (Japanese Patent Publication No. 51-32640), (4) A method of converting vincamic acid into an acid chloride and reacting it with a corresponding alcohol (Spanish Patent No. 484651), 5) A method in which a salt of apovincamic acid is reacted with a corresponding alcohol halide or sulfate in the presence of a phase transfer catalyst (Japanese Patent Application Laid-Open No. 1983-8187), (6) A method in which a salt of apovincamic acid is reacted with diazoethane (Spain) Patent No. 525772), (7)
A method of reacting apovincamic acid with the corresponding alcohol halide in dimethylformamide in the presence of a metal hydride (German Patent No. 2421999), (8) Apovincamic acid salt with the corresponding alcohol and a halogenated sulfonyl or halogenated carbonate ester A method of reacting in the presence of (JP-A-63-93782
Publication No.) etc. are known.
発明が解決しようとする課題
従来の方法をうまく組み合わせても、ビンカミンからア
ポビンカミン酸エステルに変換させるためには3工程が
必要であり、煩雑な操作を必要とするとともに通算収率
も高いものとはいえない。Problems to be Solved by the Invention Even if conventional methods are successfully combined, converting vincamine to apovincamic acid ester requires three steps, which requires complicated operations and has a high total yield. I can't say that.
本発明は、ビンカミンから同一容器内で実質的に一工程
で収率良くアポビンカミン酸エステルを製造する方法を
提供することを目的とする。An object of the present invention is to provide a method for producing apovincamic acid ester from vincamine in substantially one step in a high yield in the same container.
課題を解決するための手段
本発明は、式(II)
で表わされるビンカミンと、式(III)R−OH(I
II)
(式中、Rは炭素数2〜8のアルキル基を表わす)で表
わされるアルコールとを、ルイス酸の存在下に反応させ
ることを特徴とする式(I)(式中、Rは前記と同義で
ある)
で表わされるアポビンカミン酸エステルの製造法に関す
る。Means for Solving the Problems The present invention provides vincamine represented by formula (II) and R-OH (I
II) (wherein R represents an alkyl group having 2 to 8 carbon atoms) is reacted with an alcohol represented by the formula (I) (wherein R represents an alkyl group having 2 to 8 carbon atoms) in the presence of a Lewis acid (synonymous with)).
ここでRの定義における炭素数2〜8のアルキル基は、
直鎮または分岐状のアルキル基、例えハエチル、n−プ
ロピル、イソプロピル、nブチル、イソブチル、n−ペ
ンチル、イソアミルなどがあげられる。Here, the alkyl group having 2 to 8 carbon atoms in the definition of R is
Straight or branched alkyl groups, such as ethyl, n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isoamyl, and the like.
次にアポビンカミン酸エステルの製造法について、より
具体的に説明する。反応は、ビンカミンと対応するアル
コールとをルイス酸存在下に所望により溶媒中で反応さ
せることにより、目的化合物を得ることができる。Next, the method for producing apovincamic acid ester will be explained in more detail. In the reaction, the target compound can be obtained by reacting vincamine with the corresponding alcohol in the presence of a Lewis acid in a solvent if desired.
使用するアルコールは、目的とするアポビンカミン酸エ
ステルに対応するアルコールを原料ビンカミンの5〜2
00倍量が用いられる。The alcohol to be used is the alcohol corresponding to the desired apovincamic acid ester.
00x amount is used.
ルイス酸としては、塩化亜鉛、塩化アルミニウム、三弗
化ホウ素、塩化第二錫、塩化第二鉄、臭化亜鉛、四塩化
チタンなどの電子受容性を持つハロゲン化金属が用いら
れ、添加量はビンカミンの10〜200%(重量比)を
反応開始時に、もしくは数回に分けて加えられる。また
反応を加速するために、二種のルイス酸を組合わせて用
いても良い。組合わせて用いる場合、同時に加えてもよ
いが、別々に加えるのがより好ましく、またこの場合も
数回に分けて加えてもよい。Electron-accepting metal halides such as zinc chloride, aluminum chloride, boron trifluoride, stannic chloride, ferric chloride, zinc bromide, and titanium tetrachloride are used as Lewis acids, and the amount added is 10 to 200% (by weight) of vincamine can be added at the start of the reaction or in several portions. Further, in order to accelerate the reaction, two types of Lewis acids may be used in combination. When used in combination, they may be added at the same time, but it is more preferable to add them separately, and in this case also, they may be added in several portions.
反応は、室温〜200℃、好ましくはアルコールの沸点
で還流する温度で行われ、アルコールの種類または反応
温度によって異なるが、通常1〜80時間で完了する。The reaction is carried out at room temperature to 200° C., preferably at a temperature that is refluxing at the boiling point of the alcohol, and is usually completed in 1 to 80 hours, depending on the type of alcohol or reaction temperature.
なお、反応は常圧で行っても良いが、耐圧反応容器中で
沸点以上に加熱し、反応を促進させることもできる。The reaction may be carried out at normal pressure, but the reaction may also be accelerated by heating above the boiling point in a pressure-resistant reaction vessel.
反応の終了は、通常薄層クロマトグラフィー(TLC)
あるいは高速液体クロマトグラフィー (HPLC)な
どでビンカミンが消失することにより確認される。The reaction is usually terminated by thin layer chromatography (TLC).
Alternatively, it can be confirmed by the disappearance of vincamine using high performance liquid chromatography (HPLC) or the like.
反応混合物からアポビンカミン酸エステルを単離精製す
るには、常法により溶媒抽出し、再結晶などにより行う
ことができる。Isolation and purification of apovincamic acid ester from the reaction mixture can be carried out by solvent extraction using a conventional method, followed by recrystallization.
なおまた、アポビンカミン酸エステルは、必要に応じそ
の酸付加塩にすることができる。この場合、方法は適宜
選択されるが、例えばアポビンカミン酸エステルにエタ
ノールなどの極性溶媒に溶解した有機酸を加え溶解し、
この溶液を無水エーテルなどの不活性溶媒中に攪拌下に
滴下することにより、アポビンカミン酸エステルの酸付
加塩を得ることができる。ここで、有機酸としては、酒
石酸、マレイン酸、メタンスルフォン酸などが例示され
、特に酒石酸が好適に用いられる。Furthermore, apovincamic acid ester can be converted into its acid addition salt if necessary. In this case, the method is selected as appropriate, but for example, an organic acid dissolved in a polar solvent such as ethanol is added to apovincamic acid ester and dissolved;
By dropping this solution into an inert solvent such as anhydrous ether while stirring, an acid addition salt of apovincamic acid ester can be obtained. Here, examples of the organic acid include tartaric acid, maleic acid, methanesulfonic acid, etc., and tartaric acid is particularly preferably used.
このように、ビンカミンを出発原料として同一容器内で
実質的に一工程により、簡便な操作で式(1)で表わさ
れるアポビンカミン酸エステルもしくはその酸付加塩を
得ることができる。In this way, an apovincamic acid ester or an acid addition salt thereof represented by the formula (1) can be obtained by a simple operation using vincamine as a starting material in substantially one step in the same container.
以下の実施例により本発明の詳細な説明する。The following examples provide a detailed explanation of the invention.
実施例1
アポビンカミン酸 エチルエステルの製造ビンカミン5
00mgを20m1!のエタノールに溶解し、加熱還流
しながら塩化亜鉛250mgを4回に分けて加えた。3
8時間加熱還流させた後、500mgの塩化アルミニウ
ムを加え、加熱還流をさらに8時間続けた。反応液を冷
却し、溶媒を減圧濃縮した後、残渣に20−の酢酸エチ
ルと水とを加え、良く攪拌しながら水層がpH7になる
よう水酸化ナトリウムで調整した。Example 1 Production of apovincamic acid ethyl ester Vincamine 5
20ml of 00mg! was dissolved in ethanol, and 250 mg of zinc chloride was added in four portions while heating under reflux. 3
After heating at reflux for 8 hours, 500 mg of aluminum chloride was added and heating at reflux was continued for an additional 8 hours. After cooling the reaction solution and concentrating the solvent under reduced pressure, 20-ethyl acetate and water were added to the residue, and the pH of the aqueous layer was adjusted to 7 with sodium hydroxide while stirring well.
有機層を分離し、飽和重曹水、飽和食塩水で洗浄後減圧
濃縮し、得られた淡黄色固体をエタノールより再結晶し
、425mg(収率84.5%)の結晶を得た。この結
晶は、HPLCにおいて単一のピークを示した。The organic layer was separated, washed with saturated aqueous sodium bicarbonate and saturated brine, and concentrated under reduced pressure. The resulting pale yellow solid was recrystallized from ethanol to obtain 425 mg (yield: 84.5%) of crystals. This crystal showed a single peak on HPLC.
比旋光度〔αf、: −+ 118.2°(C・1.ピ
リジン)質量分析(m/z) 350 (M) ”実
施例2
アポビンカミン酸 n−ブチルエステルの製造ビンカミ
ン400mgと塩化アルミニウム200mgとに15−
のn−ブタノールを加え、6時間加熱還流させた。反応
液を冷却し、溶媒を減圧濃縮した後、残渣に20m1の
酢酸エチルと水とを加え、良く攪拌しながら水層がpH
7になるよう水酸化ナトリウムで調整した。有機層を分
離し、飽和重曹水、飽和食塩水で洗浄後減圧濃縮し、得
られた淡黄色液体をシリカゲルカラムクロマトグラフィ
ー(溶出溶媒:酢酸エチル)により精製することにより
、無色油状物質としてアポビンカミン酸 n−ブチルエ
ステル385mg(収率90.2%)を得た。Specific optical rotation [αf,: −+ 118.2° (C・1.Pyridine) Mass spectrometry (m/z) 350 (M) “Example 2 Production of apovincamic acid n-butyl ester 400 mg of vincamine and 200 mg of aluminum chloride. 15-
of n-butanol was added thereto, and the mixture was heated under reflux for 6 hours. After cooling the reaction solution and concentrating the solvent under reduced pressure, 20 ml of ethyl acetate and water were added to the residue, and the aqueous layer was adjusted to pH while stirring well.
It was adjusted with sodium hydroxide so that the concentration was 7. The organic layer was separated, washed with saturated aqueous sodium bicarbonate and saturated brine, and then concentrated under reduced pressure. The pale yellow liquid obtained was purified by silica gel column chromatography (elution solvent: ethyl acetate) to produce apovincamic acid as a colorless oil. 385 mg (yield 90.2%) of n-butyl ester was obtained.
比旋光度〔αC・+77.5°(c=1. ピリジン
)質量分析(m/z) 37B (M) ”実施例3
アポビンカミン酸 n−プロピルエステルの製造
0
ビンカミン500mgと塩化第二鉄500mgとに20
m1のn−プロパツールを加え18時間加熱還流させた
。反応液を冷却し、減圧濃縮した後以下実施例2と同様
の操作を行うことによりアポビンカミン酸 n−プロピ
ルエステル436mg (収率83.8%)を得た。Specific optical rotation [αC・+77.5° (c=1.Pyridine) Mass spectrometry (m/z) 37B (M) “Example 3 Production of apovincamic acid n-propyl ester 0 500 mg of vincamine and 500 mg of ferric chloride 20 to 20
ml of n-propanol was added and heated under reflux for 18 hours. After the reaction solution was cooled and concentrated under reduced pressure, the same operation as in Example 2 was performed to obtain 436 mg of apovincamic acid n-propyl ester (yield: 83.8%).
比旋光度〔αC・+50,3°(C・1.ピリジン)質
量分析(m/z) 364(M)”実施例4
アポビンカミン酸 エチルエステルの製造ビンカミン5
00mgと塩化第二鉄500mgとに20m1のエタノ
ールを加え、耐圧容器中密閉し、140℃で6時間加熱
した。反応液を冷却後以下実施例1と同様の操作を行う
ことによりアポビンカミン酸 エチルエステル392m
g(収率79.3%)を得た。Specific optical rotation [αC・+50.3° (C・1.Pyridine) Mass spectrometry (m/z) 364 (M)” Example 4 Production of apovincamic acid ethyl ester Vincamine 5
00 mg of ferric chloride and 500 mg of ferric chloride were added with 20 ml of ethanol, sealed in a pressure-resistant container, and heated at 140° C. for 6 hours. After cooling the reaction solution, the same operation as in Example 1 was carried out to obtain 392m of apovincamic acid ethyl ester.
g (yield 79.3%) was obtained.
実施例5.6
実施例4で用いたエタノールの代わりにnプロパツール
またはn−ブタノールのアルコールを用い、実施例4と
同様の操作を行うことに1
発明の効果
本発明により、ビンカ
程で収率良くアポビンカ
することができる。Example 5.6 The same operation as in Example 4 was carried out using n-propanol or n-butanol alcohol instead of the ethanol used in Example 4. Apovinca can be done easily.
ミンから実質的に一エ
ミン酸エステルを製造
より淡黄色液体が得られ、これを実施例2と同様に単離
精製することによりそれぞれ第1表に記載の結果を得た
。A pale yellow liquid was obtained by producing substantially monoemic acid ester from amine, and this was isolated and purified in the same manner as in Example 2 to obtain the results shown in Table 1.
第 1 表
実施例7
アポビンカミン酸 エチルエステルの製造ビンカミン5
00mgと臭化亜鉛500mgとに20m1のエタノー
ルを加え、耐圧容器中密閉し120℃で、6時間加熱し
た。反応液を約80℃まで冷却し、0.5mlの四塩化
チタンを加え、常圧で3時間加熱還流させた。反応液を
冷却後溶媒を減圧留去させ、実施例1と同様の操作を行
うことによりアポビンカミン酸 エチルエステル385
mg(収率77.9%)を得た。Table 1 Example 7 Production of apovincamic acid ethyl ester Vincamine 5
20 ml of ethanol was added to 00 mg of zinc bromide and 500 mg of zinc bromide, and the mixture was sealed in a pressure-resistant container and heated at 120° C. for 6 hours. The reaction solution was cooled to about 80° C., 0.5 ml of titanium tetrachloride was added, and the mixture was heated under reflux at normal pressure for 3 hours. After cooling the reaction solution, the solvent was distilled off under reduced pressure, and the same operation as in Example 1 was performed to obtain apovincamic acid ethyl ester 385.
mg (yield 77.9%).
22
Claims (2)
わされるアルコールとを、ルイス酸の存在下に反応させ
ることを特徴とする式( I ) ▲数式、化学式、表等があります▼( I ) (式中、Rは前記と同義である) で表わされるアポビンカミン酸エステルの製造法。(1) Formula (II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (II) Vincamine represented by the formula (III) R-OH (III) (wherein, R is an alkyl group having 2 to 8 carbon atoms) The formula (I) is characterized by reacting an alcohol represented by A method for producing apovincamic acid ester represented by
ホウ素、塩化第二錫、塩化第二鉄、臭化亜鉛、四塩化チ
タンの中から一種または二種の組合わせで用いられる請
求項(1)記載の製造法。(2) Claims in which the Lewis acid is used in combination of one or two selected from zinc chloride, aluminum chloride, boron trifluoride, tin chloride, ferric chloride, zinc bromide, and titanium tetrachloride ( 1) Manufacturing method described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33893689A JPH03197482A (en) | 1989-12-27 | 1989-12-27 | Production of apovincaminic acid ester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33893689A JPH03197482A (en) | 1989-12-27 | 1989-12-27 | Production of apovincaminic acid ester |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03197482A true JPH03197482A (en) | 1991-08-28 |
Family
ID=18322720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP33893689A Pending JPH03197482A (en) | 1989-12-27 | 1989-12-27 | Production of apovincaminic acid ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03197482A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0672413A4 (en) * | 1991-12-10 | 1995-02-08 | Taisho Pharmaceutical Co Ltd | Novel use of (+)-2-nitroxyethyl apovincaminate. |
-
1989
- 1989-12-27 JP JP33893689A patent/JPH03197482A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0672413A4 (en) * | 1991-12-10 | 1995-02-08 | Taisho Pharmaceutical Co Ltd | Novel use of (+)-2-nitroxyethyl apovincaminate. |
EP0672413A1 (en) * | 1991-12-10 | 1995-09-20 | Taisho Pharmaceutical Co. Ltd | Novel use of (+)-2-nitroxyethyl apovincaminate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111170855A (en) | Compound and method for synthesizing 8-hydroxy-2, 2,14, 14-tetramethylpentadecanedioic acid by using same | |
US5034541A (en) | Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z | |
JPS584785A (en) | Manufacture of isosorbide-2-nitrate | |
HU195478B (en) | Process for the production of azulene-derivatives | |
JPH03197482A (en) | Production of apovincaminic acid ester | |
Mertes et al. | Isolation and identification of the cis-trans stereoisomers of substituted 3-hydroxy-(or acetoxy) 2-methyl-2, 3-dihydrobenzofurans. Dihydrobenzofurans which obey the Karplus equation | |
US3073826A (en) | 3-pyrrolidylmethyl-4-quinazolones | |
CN114163380A (en) | Alavazepam intermediate, preparation method and application thereof | |
CN106279117A (en) | A kind of synthetic method of Lei Dipawei intermediate and products thereof | |
JPS6031823B2 (en) | Method for producing carbazole derivatives | |
US4414418A (en) | Process for the production of dimedone | |
US3920672A (en) | Thiacycl (2.2.2.)azine carboxylic acids | |
JPS603383B2 (en) | Method for producing 6-chloro-α-methyl-carbazole-2-acetic acid | |
JPS59176234A (en) | P-nitrophenyl-3-bromo-2,2-diethoxy-propionate | |
JPH04368375A (en) | Isoxazole derivative | |
JPH03503891A (en) | Production of 2,6-dioxopiperidine derivatives | |
JPS6160673A (en) | Preparation of guanidinothiazole derivative | |
STERN et al. | Synthesis of (-)-6-exo, 7-endo-Dihydroxy-3-tropanone; An Optically Active Product from a Robinson-Mannich Condensation1 | |
EP0050385B1 (en) | Piridoxine derivatives, a process for their preparation and related pharmaceutical compositions | |
JP2880203B2 (en) | Preparation of furanone derivatives | |
SU578882A3 (en) | Method of preparing triazoloquinoline derivatives | |
JPH10287657A (en) | Production of radiosensitizer | |
KR810000801B1 (en) | Process for production of 2-tetrahydrofurfuryl-6,7 benzomorphanes | |
US3197487A (en) | Salts of 2-methyl-5-dimethylaminomethyl-3-carboxylic acid and its esters | |
JPS6272672A (en) | Novel imidazole compound and production thereof |